What youll learn: GLP-1 medications help manage appetite and blood sugar, and slow digestion, making them widely used for both diabetes management and weight loss
Ideal candidates typically include: Adults with a BMI of 30 or higher (classified as obese) Adults with a BMI of 27 or higher who have at least one weight-related condition, such as type 2 diabetes, hypertension, high cholesterol, PCOS, or obstructive sleep apnea Individuals who have tried diet and exercise consistently but havent achieved meaningful weight loss Patients seeking a non-surgical, medication-based alternative to bariatric procedures People with insulin resistance, prediabetes, or blood sugar management challenges Semaglutide is not recommended for patients who are pregnant, breastfeeding, or planning to conceive, as well as those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
Your Semaglutide injection schedule (whether weekly or as directed) remains unchanged, and no dose adjustments to either therapy are needed based on evidence
Treatment typically begins at the lowest dose with increases every four weeks based on tolerability
( d ) Change in mitochondrial mass measured by NAO staining of HCT116 cells treated 5FU or 5FU + z-VAD-fmk
Why it works: Creatine & Acetyl-L-Carnitine Energy Plus contains clinically studied creatine and acetyl-L-carnitine